ImmuCell Corporation License Costs (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported License Costs (Deprecated 2018-01-31) of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2016-03-25
- ImmuCell Corporation license costs (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $500.00K.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for the quarter ending 2013-09-30 was -$250.00K.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for fiscal 2015 was $0.00.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for fiscal 2013 was $250.00K.
- ImmuCell Corporation license costs (deprecated 2018-01-31) for fiscal 2012 was $0.00.
| Period end | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 3 month as first filed | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 9 month | License Costs (Deprecated 2018-01-31) 9 month as first filed | License Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-25 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 derived: sum of 2 quarters · filed 2016-03-25 | $0.00 10-K · filed 2016-03-25 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | ||||
| 2013-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $250.00K derived: sum of 2 quarters · filed 2016-03-25 | $250.00K 10-K · filed 2016-03-25 | |||
| 2013-09-30 | -$250.00K 10-Q · filed 2014-11-12 | $250.00K 10-Q · filed 2013-11-13 | -$250.00K 10-Q · filed 2014-11-12 | $250.00K 10-Q · filed 2013-11-13 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 derived: sum of 2 quarters · filed 2015-03-26 | $0.00 10-K · filed 2015-03-26 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-26 | |||||
| 2004-12-31 | $965.00K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |